Quantcast

Latest Clinical trial Stories

2014-11-03 16:26:26

NBI-98854 Phase III Program Underway for Tardive Dyskinesia SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc.

2014-11-03 12:27:41

Velos recently activated its Investigational Drug System at The University of Texas MD Anderson Cancer Center FREMONT, Calif., Nov.

2014-10-31 16:23:58

MONTREAL, Oct. 31, 2014 /CNW Telbec/ - JSS Medical Research Inc. is pleased to announce that founder and CEO Dr. John S.

2014-10-31 08:26:32

Conference Call Scheduled for Monday, November 3, 2014 at 10:00 a.m. Eastern time JERUSALEM, October 31, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc.

2014-10-31 08:26:08

SAN DIEGO, Oct. 31, 2014 /PRNewswire/ -- Mast Therapeutics, Inc.

2014-10-30 23:10:48

DMG Productions explores the latest breakthroughs in health and medicine. Zug, Switzerland (PRWEB) October 30, 2014 PSI CRO (PSI) announced that they

2014-10-30 23:08:29

DrugDev is sponsoring and providing speakers for the 13th Annual Partnerships in Clinical Trials Congress in Barcelona, 4-6 November.

2014-10-30 16:29:19

LEXINGTON, Mass., Oct.

2014-10-30 16:28:46

Conference call to be held on Thursday, October 30, 2014 at 4:30 p.m. Eastern Time BOTHELL, Wash., and VANCOUVER, British Columbia, Oct.

2014-10-30 08:36:39

NOTTINGHAM, United Kingdom, Oct.


Word of the Day
postliminy
  • In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
  • In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.
The word 'postliminy' comes from a Latin word meaning 'threshold'.